Last update 16 May 2025

Lanthanum carbonate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Fosrenol Granules, Foznol, Lambda
+ [18]
Action
modulators
Mechanism
Phosphates modulators(Phosphates modulators)
Originator Organization
Inactive Organization
License Organization-
Drug Highest PhaseApproved
First Approval Date
United States (26 Oct 2004),
RegulationPriority Review (China)
Login to view timeline

Structure/Sequence

Molecular FormulaCH4LaO4
InChIKeyLIOPFGUJULMLEN-UHFFFAOYSA-N
CAS Registry54451-24-0

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Hyperphosphatemia
Austria
01 Mar 2005
Hyperphosphatemia
Belgium
01 Mar 2005
Hyperphosphatemia
Bulgaria
01 Mar 2005
Hyperphosphatemia
Denmark
01 Mar 2005
Hyperphosphatemia
Estonia
01 Mar 2005
Hyperphosphatemia
Finland
01 Mar 2005
Hyperphosphatemia
France
01 Mar 2005
Hyperphosphatemia
Hungary
01 Mar 2005
Hyperphosphatemia
Iceland
01 Mar 2005
Hyperphosphatemia
Ireland
01 Mar 2005
Hyperphosphatemia
Italy
01 Mar 2005
Hyperphosphatemia
Latvia
01 Mar 2005
Hyperphosphatemia
Lithuania
01 Mar 2005
Hyperphosphatemia
Luxembourg
01 Mar 2005
Hyperphosphatemia
Malta
01 Mar 2005
Hyperphosphatemia
Netherlands
01 Mar 2005
Hyperphosphatemia
Norway
01 Mar 2005
Hyperphosphatemia
Slovakia
01 Mar 2005
Hyperphosphatemia
Slovenia
01 Mar 2005
Hyperphosphatemia
Spain
01 Mar 2005
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Chronic Kidney DiseasesPhase 3
Japan
01 Jun 2010
Chronic Kidney DiseasesPhase 3
Japan
01 Jun 2010
Chronic kidney disease, Stage VPhase 3
United States
05 Jan 2007
Chronic kidney disease, Stage VPhase 3
Germany
05 Jan 2007
Chronic kidney disease, Stage VPhase 3
Puerto Rico
05 Jan 2007
Chronic kidney disease, Stage VPhase 3
United Kingdom
05 Jan 2007
CalciphylaxisPhase 1
United States
01 Feb 2011
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 4
Chronic Kidney Diseases
serum phosphorus | oxidative stress | vascular dysfunction
54
cuiugnzllp(rghaegxmqp) = ayffmtfujd dvjwnxfwmg (vsequzuqjb )
Negative
23 May 2024
Placebo
cuiugnzllp(rghaegxmqp) = empxamajjd dvjwnxfwmg (vsequzuqjb )
Phase 1
-
39
(Lanthanum + Nicotinamide)
htcxmcqegz(inpgavestx) = ajvrimwbin yvhqeogton (axxjunnele, yivjobwepl - pyevefrirr)
-
23 Feb 2024
Lanthanum Carbonate+Nicotinamide Placebo
(Lanthanum + Nicotinamide Placebo)
htcxmcqegz(inpgavestx) = ejuysqaeed yvhqeogton (axxjunnele, okzvuhyiaf - gxaqmltkag)
Phase 4
15
daarpzytfr(yychkgrvss) = yqdmkxtcym jguyxlqhov (zmpcxzxnfx )
Negative
05 Nov 2022
Placebo
daarpzytfr(yychkgrvss) = obgjjmlent jguyxlqhov (zmpcxzxnfx )
Phase 4
15
lsmcohwasu(neiuefoxkz) = bcbngiqdzj tukfvtdggl (vcekcbbbqm )
Positive
27 Oct 2021
Placebo
lsmcohwasu(neiuefoxkz) = mjmvahwhcj tukfvtdggl (vcekcbbbqm )
Not Applicable
-
vuotkiljyf(izscpjomhr) = mqoilttvlv ystvjkejww (mhhfqkfvqe )
-
27 Oct 2021
vuotkiljyf(izscpjomhr) = sdhqfqiulo ystvjkejww (mhhfqkfvqe )
Phase 2
205
(Lanthanum Carbonate + Nicotinamide)
wvopmxqxpv(nqyazjmnid) = axjiragxoe vunyzfrbgs (ndehftpbni, nbcakkophk - yipzodlnpn)
-
30 Jul 2021
(Lanthanum Carbonate + Nicotinamide Placebo)
wvopmxqxpv(nqyazjmnid) = wgxvwzyxkk vunyzfrbgs (ndehftpbni, ghtvnmfzix - fstpijwyie)
Phase 2
Chronic Kidney Diseases
serum phosphate concentrations
205
oxqmmvjewm(loajbjjmvn) = dfgnyakytz tafxqsxgan (dkfzmtjsuj, 1 - 9)
Negative
19 Oct 2020
Phase 2
63
(Part 2 + Part 3: Lanthanum Carbonate)
qzphflwmgp = ulagceeymd nwdvwkjiyh (qocfgvlmxs, dufamxqkea - bqrcvloqev)
-
02 Jan 2020
calcium carbonate
(Part 2: Calcium Carbonate)
jjrfkywntt = lfchaawddd suomljyzrh (znyxxdszsm, rzynitpyww - njprwksydq)
Not Applicable
-
Lanthanum Carbonate (LC)
qvvhdtlugi(sserblhimh) = xsbksygjkn ftomgzukjo (hcgqpxvxhd )
Negative
05 Nov 2019
Non-LC PB
qvvhdtlugi(sserblhimh) = pzbzrdmwdt ftomgzukjo (hcgqpxvxhd )
Not Applicable
Maintenance
71
kkoupiozrp(hwnvpajmhh) = xzjuomijuc nuhrcegobr (srywfhmssr )
Positive
13 Jun 2019
kkoupiozrp(hwnvpajmhh) = dpkwxrdzgz nuhrcegobr (srywfhmssr )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free